The investigation of the association of low-dose aspirin and reflux esophagitis
Not Applicable
- Conditions
- Reflux esophagitis
- Registration Number
- JPRN-UMIN000014543
- Lead Sponsor
- Oita university, department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with active gastric ulcer or duodenal ulcer. 2. Patients with hypersensitivity to esomeprazole. 3. Patients in the administration of atazanavir sulfate or a Rirupibirin hydrochloride. 4. Patients with chronic alcoholism or drug dependence. 5. Patients with warning symptoms, such as vomitting, or sudden weight loss. 6. The patient who has difficulty in participation in this examination by the mergers such as a serious liver disease, renal disease, or heart trouble. 7. Pregnant women, nursing girls or the women who may be pregnant. 8. Patients who judged unsuitable for research participation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The risk odds ratio of the low-dose aspirin for the reflux esophagitis onset
- Secondary Outcome Measures
Name Time Method The rate that reflux esophagitis improves by proton pump inhibitor administration